Complementation of NADPH oxidase in p67-phox-deficient CGD patients - p67-phox/p40-phox interaction

被引:57
作者
Vergnaud, S
Paclet, MH
El Benna, J
Pocidalo, MA
Morel, F
机构
[1] Univ Grenoble 1, MENRT, GREPI EA 2938, Lab Enzymol,CHU, F-38043 Grenoble 9, France
[2] CHU Bichat, INSERM, U479, Paris, France
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2000年 / 267卷 / 04期
关键词
chronic granulomatous disease; EBV-B lymphocytes; p40-phox inhibition; p67-phox;
D O I
10.1046/j.1432-1327.2000.01097.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic granulomatous disease (CGD) is due to a functional defect of the O-2(-) generating NADPH oxidase of phagocytes. Epstein-Barr-virus-immortalized B lymphocytes express all the constituents of oxidase with activity 100 times less than that of neutrophils. As in neutrophils, oxidase activity of Epstein-Barr-virus-immortalized B lymphocytes was shown to be defective in the different forms of CGD; these cells were used as a model for the complementation studies of two p67-phox-deficient CGD patients. Reconstitution of oxidase activity was performed in vitro by using a heterologous cell-free assay consisting of membrane-suspended or solubilized and purified cytochrome b(558) that was associated with cytosol or with the isolated cytosolic-activating factors (p67-phox, p47-phox, p40-phox) from healthy or CGD patients. In p67-phox-deficient CGD patients, two cytosolic factors are deficient or missing: p67-phox and p40-phox. Not more than 20% of oxidase activity was recovered by complementing the cytosol of p67-phox-deficient patients with recombinant p67-phox. On the contrary, a complete restoration of oxidase activity was observed when, instead of cytosol, the cytosolic factors were added in the cell-free assay after isolation in combination with cytochrome b(558) purified from neutrophil membrane. Moreover, the simultaneous addition of recombinant p67-phox and recombinant p40-phox reversed the previous complementation in a p40-phox dose-dependent process. These results suggest that in the reconstitution of oxidase activity, p67-phox is the limiting factor; the efficiency of complementation depends on the membrane tissue and the cytosolic environment. In vitro, the transition from the resting to the activated state of oxidase, which results from assembling, requires the dissociation of p40-phox from p67-phox for efficient oxidase activity. In the process, p40-phox could function as a negative regulatory factor and stabilize the resting state.
引用
收藏
页码:1059 / 1067
页数:9
相关论文
共 43 条
[1]  
Aoshima M, 1996, BLOOD, V88, P1841
[2]   NADPH oxidase: An update [J].
Babior, BM .
BLOOD, 1999, 93 (05) :1464-1476
[3]   Biochemical and immunochemical properties of B lymphocyte cytochrome b558 [J].
Batot, G ;
Paclet, MH ;
Doussière, J ;
Vergnaud, S ;
Martel, C ;
Vignais, PV ;
Morel, F .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1406 (02) :188-202
[4]   CHARACTERIZATION OF NEUTROPHIL NADPH OXIDASE ACTIVITY RECONSTITUTED IN A CELL-FREE ASSAY USING SPECIFIC MONOCLONAL-ANTIBODIES RAISED AGAINST CYTOCHROME B(558) [J].
BATOT, G ;
MARTEL, C ;
CAPDEVILLE, N ;
WIENTJES, F ;
MOREL, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (01) :208-215
[5]   Identification of a double mutation (D160V-K161E) in the p67phox gene of a chronic granulomatous disease patient [J].
Bonizzato, A ;
Russo, MP ;
Donini, M ;
Dusi, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) :861-863
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   LOW NADPH OXIDASE ACTIVITY IN EPSTEIN-BARR-VIRUS-IMMORTALIZED B-LYMPHOCYTES IS DUE TO A POSTTRANSCRIPTIONAL BLOCK IN EXPRESSION OF CYTOCHROME B(558) [J].
CHETTY, M ;
THRASHER, AJ ;
ABO, A ;
CASIMIR, CM .
BIOCHEMICAL JOURNAL, 1995, 306 :141-145
[8]   ACTIVATION OF O2(-)-GENERATING OXIDASE IN AN HETEROLOGOUS CELL-FREE SYSTEM DERIVED FROM EPSTEIN-BARR-VIRUS-TRANSFORMED HUMAN LYMPHOCYTES-B AND BOVINE NEUTROPHILS - APPLICATION TO THE STUDY OF DEFECTS IN CYTOSOLIC FACTORS IN CHRONIC GRANULOMATOUS-DISEASE [J].
COHENTANUGI, L ;
MOREL, F ;
PILLOUDDAGHER, MC ;
SEIGNEURIN, JM ;
FRANCOIS, P ;
BOST, M ;
VIGNAIS, PV .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 202 (02) :649-655
[9]   The mechanism of activation of NADPH oxidase in the cell-free system: the activation process is primarily catalytic and not through the formation of a stoichiometric complex [J].
Cross, AR ;
Erickson, RW ;
Curnutte, JT .
BIOCHEMICAL JOURNAL, 1999, 341 :251-255
[10]   AUTOSOMAL RECESSIVE CHRONIC GRANULOMATOUS-DISEASE WITH ABSENCE OF THE 67-KD CYTOSOLIC NADPH OXIDASE COMPONENT - IDENTIFICATION OF MUTATION AND DETECTION OF CARRIERS [J].
DEBOER, M ;
HILARIUSSTOKMAN, PM ;
HOSSLE, JP ;
VERHOEVEN, AJ ;
GRAF, N ;
KENNEY, RT ;
SEGER, R ;
ROOS, D .
BLOOD, 1994, 83 (02) :531-536